OPKO Health to exchange $152.5M convertible notes for 116.7M shares and ~$60.1M cash

OPKO HEALTH, INC.

Exchange of $152,471,000 principal of 3.75% Convertible Senior Notes due 2029 for 116,706,310 common shares and ~$60.1M cash, including accrued interest.
Closing scheduled April 1, 2025; Exchanged Notes will be retired.
Shares issued unregistered under Section 4(a)(2) based on Noteholder representations as QIBs or accredited investors.
Transaction reduces debt and interest expense but dilutes existing shareholders by adding 116.7M new shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.